News : July 18, 2019

Improving outcomes with Vivostat PRF

Alastair and his colleagues have successfully applied the use of this cutting-edge technology.

Vivostat PRF (Platelet Rich Fibrin) combines patients’ own clotting and healing factors along with antibiotics to reduce the risk of wound infections and bleeding complications. The outcomes of this have been presented at a big national conference for surgery.

Using this and other innovative techniques and highest quality precision surgery, Alastair and his team have managed to decrease the complication rates even further cementing their position as providing outcomes that can not be bettered anywhere else in the world.